Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
20.68
-0.10 (-0.48%)
At close: Apr 23, 2026, 4:00 PM EDT
20.59
-0.09 (-0.44%)
After-hours: Apr 23, 2026, 5:30 PM EDT
Tandem Diabetes Care Employees
Tandem Diabetes Care had 2,500 employees as of December 31, 2025. The number of employees decreased by 150 or -5.66% compared to the previous year.
Employees
2,500
Change (1Y)
-150
Growth (1Y)
-5.66%
Revenue / Employee
$405,894
Profits / Employee
-$81,884
Market Cap
1.42B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,500 | -150 | -5.66% |
| Dec 31, 2024 | 2,650 | 250 | 10.42% |
| Dec 31, 2023 | 2,400 | -200 | -7.69% |
| Dec 31, 2022 | 2,600 | 600 | 30.00% |
| Dec 31, 2021 | 2,000 | 500 | 33.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AdaptHealth | 10,900 |
| Enovis | 7,802 |
| UFP Technologies | 4,846 |
| CONMED | 3,900 |
| Avanos Medical | 2,287 |
| NovoCure | 1,605 |
| Inspire Medical Systems | 1,333 |
| Alphatec Holdings | 913 |
TNDM News
- 21 days ago - Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026 - Business Wire
- 27 days ago - Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire
- 5 weeks ago - Bullish Call On Tandem Diabetes Signals Long-Term Growth Confidence - Benzinga
- 7 weeks ago - Tandem Mobi Now Compatible with Android Smartphones - Business Wire
- 2 months ago - Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032 - Business Wire
- 2 months ago - Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes - Business Wire
- 2 months ago - Tandem Diabetes Shares Rise 33% On Earnings Beat, Margin Expansion, Growth Outlook - Benzinga
- 2 months ago - Tandem Diabetes Care Analysts Boost Their Forecasts After Upbeat Q4 Results - Benzinga